​

scPharmaceuticals (SCPH) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

scPharmaceuticals Revenue Highlights

Latest Revenue (Y)

$36.33M

Latest Revenue (Q)

$8.05M

scPharmaceuticals Revenue by Period

scPharmaceuticals Revenue by Year

DateRevenueChange
2024-12-31$36.33M167.28%
2023-12-31$13.59M100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

scPharmaceuticals generated $36.33M in revenue during NA 2024, up 167.28% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

scPharmaceuticals Revenue by Quarter

DateRevenueChange
2024-06-30$8.05M31.99%
2024-03-31$6.10M0.10%
2023-12-31$6.10M60.59%
2023-09-30$3.80M131.75%
2023-06-30$1.64M-20.60%
2023-03-31$2.06M100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31--

scPharmaceuticals generated $8.05M in revenue during Q2 2024, up 31.99% compared to the previous quarter, and up 390.40% compared to the same period a year ago.

scPharmaceuticals Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
IOVAIovance Biotherapeutics$164.07M$58.55M
SCPHscPharmaceuticals$36.33M$8.05M
LYRALyra Therapeutics$1.53M$195.00K
MCRBSeres Therapeutics--
DMACDiaMedica Therapeutics--
CNTACentessa Pharmaceuticals--
MISTMilestone Pharmaceuticals--
MNPRMonopar Therapeutics--
ONCYOncolytics Biotech--
KTTAPasithea Therapeutics--

SCPH Revenue FAQ

What is scPharmaceuticals’s yearly revenue?

scPharmaceuticals's yearly revenue for 2024 was $36.33M, representing an increase of 167.28% compared to 2023. The company's yearly revenue for 2023 was $13.59M, representing an increase of 100.00% compared to 2022. SCPH's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is scPharmaceuticals’s quarterly revenue?

scPharmaceuticals's quarterly revenue for Q2 2024 was $8.05M, a 31.99% increase from the previous quarter (Q1 2024), and a 391.70% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $6.1M, a 0.10% increase from the previous quarter (Q4 2023), and a 195.78% increase year-over-year (Q1 2023). SCPH's quarterly revenue for Q4 2023 was $6.1M, a 60.59% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is scPharmaceuticals’s revenue growth rate?

scPharmaceuticals's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.